| Database ID | Agent | Target | Cancer Type | Detail |
| DB01006 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01007 | everolimus | Serine/threonineprotein kinase mTOR | thyroid cancer | view |
| DB01008 | everolimus | Serine/threonineprotein kinase mTOR | soft tissue sarcomas | view |
| DB01009 | everolimus | Serine/threonineprotein kinase mTOR | smallcell lung cancer | view |
| DB01010 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
| DB01011 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01012 | vandetanib | Epidermal growth factor receptor
Vascular endothelial growth factor receptor 2
Protooncogene tyrosineprotein kinase receptor ret | non small cell lung cancer | view |
| DB01013 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01014 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01015 | beloranib | Methionine aminopeptidase2 | colorectal cancer | view |
| DB01016 | bevacizumab | Vascular endothelial growth factor | non small cell lung cancer | view |
| DB01017 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01018 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01019 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB01020 | beloranib | Methionine aminopeptidase2 | advanced solid tumors | view |